What are the ethical and regulatory challenges in approving biosimilars in India?
An RSS-affiliated organization has sought clarity on draft guidelines for biosimilars. I am curious about the difficulties regulators face in ensuring the safety and efficacy of biosimilars and the ethical issues involved.